KRYS
Krystal Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$310.84
+1.90%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.32x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.03x
- Net debt / EBITDA
- -1.80x
Liquidity & coverage
- Current ratio
- 7.89x
- Quick ratio
- 7.53x
- Cash ratio
- 6.41x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $979.6M
Cash & dividend
- FCF / debt
- 36.11x
- Cash flow / debt
- 37.72x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026